Metabolic status of CSF distinguishes rats with tauopathy from controls.
Karlíková R, Mičová K, Najdekr L, Gardlo A, Adam T, Majerová P, Friedecký D, Kováč A.
Karlíková R, et al.
Alzheimers Res Ther. 2017 Sep 21;9(1):78. doi: 10.1186/s13195-017-0303-5.
Alzheimers Res Ther. 2017.
PMID: 28934963
Free PMC article.
CONCLUSIONS: Despite an enormous effort invested in development of biomarkers for tauopathies during the last 20 years, there is no clinically used biomarker or assay on the market. One of the most promising strategies is to create a panel of markers (e.g., small molecules …
CONCLUSIONS: Despite an enormous effort invested in development of biomarkers for tauopathies during the last 20 years, there is no clinical …